D-0492-2019 Class III Terminated
FDA drug recall D-0492-2019 was initiated by Oxalis Labs on Jan 11, 2019 and is designated Class III. Reason for recall: Defective Container; complaints of leakage. The recall status is terminated (terminated Nov 6, 2019). Affected quantity: 53,358 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 20, 2019
- Initiation Date
- Jan 11, 2019
- Termination Date
- Nov 6, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 53,358 bottles
Product description
Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufacturer: Macleods Pharmaceuticals Ltd Al Oxalis Labs Baddi Himachal Pradesh INDIA, UPC Code 33342032186 ---- NDC 33342-321-86
Reason for recall
Defective Container; complaints of leakage.
Distribution pattern
Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughout the United States.
Code information
Lot Numbers: PCA801A, PCA802A, PCA803A, exp. date 12/2019; PCA804A, PCA805A, PCA806A, PCA807A, exp. date 04/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0492-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026